Shenzhen Chipscreen Biosciences Co (SHSE:688321) Research & Development: ¥220 Mil (TTM As of Mar. 2026)


SHSE:688321 Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
72 GF Score
Price ¥28.74
GF Value ¥37.74
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shenzhen Chipscreen Biosciences Co Research & Development?

Shenzhen Chipscreen Biosciences Co SHSE:688321 +1.34% 72 Research & Development is ¥220 Mil as of Mar. 2026. GuruFocus rates SHSE:688321 with a GF Score™ of 72/100 and a GF Value™ of ¥37.74 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shenzhen Chipscreen Biosciences Co's Research & Development for the three months ended in Mar. 2026 was ¥52 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥220 Mil.

Shenzhen Chipscreen Biosciences Co  (SHSE:688321) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shenzhen Chipscreen Biosciences Co Research & Development Related Terms

Shenzhen Chipscreen Biosciences Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shenzhen Chipscreen Biosciences Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Chipscreen Biosciences Co Research & Development Chart

Shenzhen Chipscreen Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.03 163.67 270.45 213.52 221.62

Shenzhen Chipscreen Biosciences Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.91 52.61 56.87 59.23 51.62
SHSE:688321
72GF Score
Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Chipscreen Biosciences Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥220 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥220 Mil mean?
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Research & Development of ¥220 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors.
Is Shenzhen Chipscreen Biosciences Co's Research & Development too high?
Shenzhen Chipscreen Biosciences Co's current Research & Development is ¥220 Mil. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Research & Development compare to ZTS and UTHR?
Shenzhen Chipscreen Biosciences Co's Research & Development of ¥220 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. Shenzhen Chipscreen Biosciences Co's current Research & Development is ¥220 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥37.74, compared to a current price of ¥28.74 — trading 23.8% below its estimated fair value. The current Research & Development is ¥220 Mil. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Research & Development is ¥220 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued. The current stock price of ¥28.74 is trading 23.8% below its estimated GF Value™ of ¥37.74. GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Modestly Undervalued.

Key valuation signals for SHSE:688321:

  • Research & Development: ¥220 Mil
  • GF Value™: ¥37.74 vs. price of ¥28.74 (23.8% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen Chipscreen Biosciences Co Business Description

Address No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.
72GF Score

Get the complete analysis for SHSE:688321

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.74
Price
¥37.74
GF Value